Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Migraine Satellite symposium Article Raising the bar for successful migraine prevention Schizophrenia Bipolar Article Poor Heart Health Outcomes in Patients with Mental Illness Parkinson's Disease Congress highlights Article A spotlight on gene therapies for neurological diseases Migraine Satellite symposium Article Individualizing migraine therapy — the right treatment at the right time for the right patient